≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Systemic sclerosis, icd10

Endpoint Browser

SYSTSCLE_ICD10

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M34
  • Cause of death: ICD-10 — M34

2 out of 7 registries used, show all original rules.

867

4. Check minimum number of events

None

867

5. Include endpoints

None

867

6. Filter based on genotype QC (FinnGen only)

867

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF3
Parent code in ICD-10
M30-M36
Name in latin
Sclerosis systemica

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 867 716 151
Unadjusted period prevalence (%) 0.21 0.24 0.07
Median age at first event (years) 55.27 55.07 56.23

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
780
Matched controls
7798
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
5750.8
323.0
349
*
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
323.0
481
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
21.2
280.0
479
544
P01BA02
ATC
hydroxychloroquine; oral
21.9
259.7
422
398
C08CA05
ATC
nifedipine; systemic
29.6
243.7
343
201
I73.0
ICD-10 Finland
Raynaud syndrome
61.6
174.1
202
44
M34.0
ICD-10 Finland
Progressive systemic sclerosis
+∞
156.7
145
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
11.9
149.5
309
408
XX9XE
NOMESCO Finland
Other ultrasound examination
100.3
129.2
140
17
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
40.4
113.4
143
43
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
9.9
98.4
216
290
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
+∞
93.7
88
*
XPX04
NOMESCO Finland
Angioscopy
113.2
92.4
99
10
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
7.5
82.1
216
378
L04AA06
ATC
mycophenolic acid; systemic
25.9
73.8
104
46
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
10.6
70.6
145
165
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
70.2
489
2346
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.9
65.2
387
1582
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.4
64.7
296
957
L04AX01
ATC
azathioprine; systemic
9.1
60.1
134
174
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
112.1
57.7
62
6
XG410
NOMESCO Finland
Flow-volume spirometry
10.0
56.3
118
137
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
13.0
56.1
102
89
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
7.2
53.6
140
231
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
284.3
52.8
53
*
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
54.0
50.7
60
12
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
11.9
50.1
95
90
M35.1
ICD-10 Finland
Other overlap syndromes
49.0
49.0
59
13
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
11.6
47.0
90
87
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.8
46.0
142
289
H02AB06
ATC
prednisolone; systemic
2.9
44.5
487
2824
L88
ICPC
Rheumatoid/seropositive arthritis
7.1
42.3
109
174
G04BE03
ATC
sildenafil; oral
34.8
35.7
46
14
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
4.1
33.9
148
426
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.3
33.5
196
716
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
33.4
378
2094
C08CA02
ATC
felodipine; oral
4.4
33.2
130
337
M34
ICD-10 Finland
Systemic sclerosis
340.7
33.1
33
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.5
32.5
124
313
NH3EA
NOMESCO Finland
Feet X-ray examination with load
9.2
31.3
67
79
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
8.7
29.9
66
82
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
11.5
29.7
56
52
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
+∞
29.3
28
*
C02KX01
ATC
bosentan; oral
302.6
29.0
29
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.9
29.0
130
380
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
11.1
27.1
52
50
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
5.6
26.4
80
156
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
15.1
25.9
43
30
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.8
25.0
88
203
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
7.9
24.6
57
77
K74.3
ICD-10 Finland
Primary biliary cirrhosis
23.6
24.1
34
15
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
29.3
23.3
31
11
R06.0
ICD-10 Finland
Dyspnoea
2.4
23.3
244
1236
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
11.0
23.1
44
42
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.4
23.0
123
411
TGC00
NOMESCO Finland
Bronchial lavation
7.9
22.5
52
70
C08CA01
ATC
amlodipine; oral
2.2
22.4
307
1765
L04AD01
ATC
ciclosporin; systemic
8.5
22.2
49
61
E0000UV
ATC
NA
2.1
21.3
371
2353
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
7.2
20.8
51
75
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
20.8
216
1080
WZA10
NOMESCO Finland
Long statement of health and health related matters
11.0
20.6
39
37
R4120
NOMESCO Finland
Occupational therapy
3.8
20.6
93
271
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.3
20.4
113
386
J01FF01
ATC
clindamycin; systemic
2.2
19.0
253
1413
7101A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic sclerosis[SCLERODERMA]
+∞
18.8
18
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
18.4
393
2649
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
7.6
18.0
42
58
M01CC01
ATC
penicillamine; oral
68.2
17.8
20
*
G73.7*M34.8
ICD-10 Finland
Myopathy in scleroderma
+∞
17.8
17
*
C02KX04
ATC
macitentan; oral
+∞
17.8
17
*
H04.10
ICD-10 Finland
Dry eye syndrome
2.8
17.7
125
500
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
6.0
17.7
49
86
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.3
17.1
92
307
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
17.0
192
987
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
+∞
16.7
16
*
A05AA02
ATC
ursodeoxycholic acid; oral
8.2
16.7
37
47
RT160
NOMESCO Finland
NA
92.0
16.6
18
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.6
16.1
76
229
RT172
NOMESCO Finland
NA
48.6
16.1
19
*
SBA10
NOMESCO Finland
Measurement of excretion of saliva
9.3
16.1
33
37
I27.0
ICD-10 Finland
Primary pulmonary hypertension
61.3
15.8
18
*
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
13.3
15.8
27
21
L04AA01
ATC
[U] ciclosporin; systemic
7.4
15.7
37
52
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.3
15.7
82
268
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
15.5
347
2330
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.6
15.2
71
212
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.2
15.1
84
285
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
10.3
15.0
29
29
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
14.6
180
952
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
152.7
14.5
15
*
A02BC01
ATC
omeprazole; systemic
2.0
14.4
244
1471
A02BC02
ATC
pantoprazole; systemic
1.8
14.1
539
4276
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
14.0
57
152
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
54.3
13.8
16
*
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
16.5
13.5
21
13
H02AB07
ATC
prednisone; oral
2.2
13.1
144
723
C03CA01
ATC
furosemide; systemic
2.0
13.0
205
1195
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.7
12.8
43
95
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
4.1
12.8
50
129
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.6
12.8
95
388
E000001
ATC
NA
2.0
12.5
183
1035
NHQ40
NOMESCO Finland
Amputation of toe
10.7
12.3
23
22
RT272
NOMESCO Finland
NA
16.2
12.2
19
12
UJF32
NOMESCO Finland
Coloscopy
1.9
12.0
226
1399
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
11.9
119
568
M05BA04
ATC
alendronic acid; oral
2.5
11.9
94
399
R13
ICD-10 Finland
Dysphagia
3.0
11.9
72
259
M05BA07
ATC
risedronic acid; oral
3.8
11.6
48
131
D06BX01
ATC
metronidazole; topical
2.3
11.5
112
529
L99
ICPC
Musculoskeletal disease other
5.2
11.5
35
70
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
6.6
11.2
28
44
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
20.4
11.2
16
8
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
11.1
233
1491
N02AX02
ATC
tramadol; systemic, rectal
1.7
11.0
330
2355
C02DE02
ATC
NA
9.0
10.8
22
25
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
10.7
92
407
ZX120
NOMESCO Finland
Intravenous
2.4
10.7
92
408
RT271
NOMESCO Finland
NA
21.8
10.7
15
7
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.4
10.6
50
152
K22.7
ICD-10 Finland
Barrett oesophagus
8.7
10.6
22
26
SPAT1263
SPAT
Sampling
1.7
10.5
338
2446
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
5.5
10.5
30
56
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.4
10.5
51
159
M05BX04
ATC
denosumab; parenteral
2.9
10.4
62
223
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
33.0
10.4
13
*
R15
ICD-10 Finland
Faecal incontinence
4.0
10.2
40
104
R50.9
ICD-10 Finland
Fever, unspecified
2.2
10.0
111
554
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
10.0
113
572
J01DB01
ATC
cefalexin; oral
1.8
9.9
641
5595
RT274
NOMESCO Finland
NA
17.0
9.9
15
9
RT231
NOMESCO Finland
NA
55.7
9.7
11
*
XG466
NOMESCO Finland
Sleep oxymetry
4.2
9.6
35
86
S97
ICPC
Chronic ulcer skin
3.3
9.5
48
154
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
30.4
9.4
12
*
M31.4
ICD-10 Finland
Aortic arch syndrome [Takayasu]
+∞
9.4
9
*
M34.2
ICD-10 Finland
Systemic sclerosis induced by drugs and chemicals
+∞
9.4
9
*
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
9.4
9
*
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.6
9.3
70
290
S18
ICPC
Laceration/cut
1.6
9.3
322
2352
K22.1
ICD-10 Finland
Ulcer of oesophagus
6.2
9.3
24
40
A02BC05
ATC
esomeprazole; systemic
1.6
9.2
339
2516
J01MA12
ATC
levofloxacin; systemic
1.9
9.2
150
875
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
9.1
89
418
K62.3
ICD-10 Finland
Rectal prolapse
5.5
9.1
26
49
NDQ20
NOMESCO Finland
Amputation of finger
18.8
9.0
13
7
M25.5
ICD-10 Finland
Pain in joint
1.7
8.9
243
1662
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
8.9
69
288
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.5
8.8
30
69
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.6
8.7
29
65
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
6.7
8.7
21
32
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
11.7
8.6
15
13
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
16.5
8.6
13
8
J01MA14
ATC
moxifloxacin; systemic
2.3
8.5
78
356
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
8.5
83
391
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
8.5
302
2209
RT310
NOMESCO Finland
NA
27.8
8.5
11
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
8.4
140
822
N03AX16
ATC
pregabalin; oral
1.7
8.4
198
1297
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
5.6
8.3
23
42
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.5
8.3
66
281
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
3.3
8.3
40
125
SPAT1254
SPAT
Administration of medicine
2.0
8.2
112
608
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
6.1
8.2
21
35
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
3.5
8.2
36
105
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
8.1
143
855
L01AA01
ATC
cyclophosphamide; systemic
33.7
8.1
10
*
R76.0
ICD-10 Finland
Raised antibody titre
22.3
8.0
11
5
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.1
8.0
93
477
R4190
NOMESCO Finland
Nutritional therapy
3.3
7.9
38
119
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
13.2
7.9
13
10
A02BC03
ATC
lansoprazole; oral
1.6
7.9
241
1689
R1250
NOMESCO Finland
Evaluation of functional capability
4.7
7.9
25
54
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
7.8
49
182
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
15.2
7.7
12
8
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
45.4
7.7
9
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.5
7.7
57
235
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
7.7
306
2286
J02AC01
ATC
fluconazole; systemic
1.5
7.7
358
2776
RJ420
NOMESCO Finland
NA
18.6
7.6
11
6
G73.7
ICD-10 Finland
Myopathy in other diseases classified elsewhere
25.3
7.6
10
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
7.6
74
348
TEA00
NOMESCO Finland
Biopsy of lip
7.2
7.5
17
24
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
7.5
202
1367
L12
ICPC
Hand/finger symptom/complaint
1.9
7.4
117
671
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
7.4
66
300
C03DA01
ATC
spironolactone; oral
2.2
7.4
76
370
L95
ICPC
Osteoporosis
2.9
7.3
42
148
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
9.5
7.3
14
15
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
7.3
7
*
L94.9
ICD-10 Finland
Localized connective tissue disorder, unspecified
+∞
7.3
7
*
L94.3
ICD-10 Finland
Sclerodactyly
+∞
7.3
7
*
NF1AA
NOMESCO Finland
Hip X-ray examination
2.2
7.3
75
364
EBA10
NOMESCO Finland
Surgical removal of tooth
2.1
7.3
86
444
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
7.3
134
810
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.7
7.3
47
180
M05BB03
ATC
alendronic acid and colecalciferol; oral
4.0
7.2
27
69
M13.9
ICD-10 Finland
Arthritis, unspecified
2.3
7.2
64
288
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
7.2
230
1623
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
7.1
87
454
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.0
7.1
39
135
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
7.1
72
348
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.8
7.0
28
76
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.9
7.0
113
652
J01AA04
ATC
lymecycline; systemic
1.9
6.9
104
586
NDL52
NOMESCO Finland
Tenosynovectomy of hand
7.6
6.9
15
20
WX110
NOMESCO Finland
Local anesthesy
1.5
6.9
518
4419
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
6.9
183
1230
E000003
ATC
NA
2.7
6.9
44
166
C08DB01
ATC
diltiazem; oral
2.8
6.9
42
156
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
6.9
114
666
H03AA01
ATC
levothyroxine sodium; systemic
1.6
6.8
208
1447
A03FA02
ATC
cisapride; oral, rectal
2.2
6.8
69
332
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.5
6.8
30
89
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
40.4
6.8
8
*
I73.1
ICD-10 Finland
Thromboangiitis obliterans [Buerger]
40.4
6.8
8
*
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.7
6.7
43
163
GX1K5
NOMESCO Finland
Diffusion capacity
22.7
6.7
9
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
6.5
6.7
16
25
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.3
6.7
58
259
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.6
6.6
47
190
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
6.6
117
698
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.5
6.6
29
86
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.6
6.6
46
184
JGC01
NOMESCO Finland
Laparoscopic rectopexy
6.9
6.5
15
22
L84
ICD-10 Finland
Corns and callosities
3.3
6.5
30
92
Z01.9
ICD-10 Finland
Special examination, unspecified
2.5
6.5
49
205
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
6.3
6.5
16
26
A07AA02
ATC
nystatin; oral
2.3
6.5
60
278
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
5.8
6.5
17
30
Z94.2
ICD-10 Finland
Lung transplant status
70.4
6.4
7
*
RJ412
NOMESCO Finland
NA
70.4
6.4
7
*
S09
ICPC
Infected finger/toe
3.2
6.4
31
99
SPAT1312
SPAT
General health counselling
1.5
6.4
242
1769
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
5.6
6.3
17
31
J96.1
ICD-10 Finland
Chronic respiratory failure
4.6
6.3
20
44
GD1UN
NOMESCO Finland
Lung circulation SPECT
9.4
6.3
12
13
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
6.3
138
879
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.8
6.3
38
141
SPAT1211
SPAT
Application of soft bandage
2.1
6.3
68
339
B01AC27
ATC
selexipag; oral
+∞
6.3
6
*
XQ844
NOMESCO Finland
Other microscope or electron microscope examination
+∞
6.3
6
*
I27.1
ICD-10 Finland
Kyphoscoliotic heart disease
+∞
6.3
6
*
383
Kela drug reimbursment
Selexipag
+∞
6.3
6
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
6.3
130
815
M35
ICD-10 Finland
Other systemic involvement of connective tissue
26.9
6.2
8
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.5
6.2
27
80
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
6.2
103
600
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
5.8
6.2
16
28
D02AE01
ATC
carbamide; topical
2.3
6.2
56
259
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
6.1
89
497
N02AA05
ATC
oxycodone; systemic
1.8
6.1
99
572
GD2SN
NOMESCO Finland
Lung ventilation SPECT
8.7
6.1
12
14
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
6.1
60
288
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
6.0
253
1890
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.8
6.0
112
678
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
5.6
6.0
16
29

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
308
268
17.27
317.70
2.5
2.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
265
178
21.00
314.41
1.5
1.2
u/ml
0.4
—
—
9
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
368
247
25.15
307.65
1.6
1.2
u/ml
9.5
27.5
0.49
24
12
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
363
232
26.20
307.65
1.7
1.2
u/ml
7.8
5.7
0.27
131
38
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
342
174
31.81
307.65
1.5
1.2
u/ml
34.1
8.3
1.71
52
12
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
297
187
23.64
307.65
1.6
1.2
u/ml
36.6
49.8
0.36
50
19
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
363
228
26.67
307.65
1.6
1.2
u/ml
2.9
2.6
0.15
91
24
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
270
231
16.52
279.28
2.3
1.7
g/l
0.2
0.2
5.99
258
222
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
270
242
15.75
271.21
2.3
1.6
g/l
1.1
1.2
7.08
258
230
(3015171) Extractable nuclear Ab [Units/volume] in Serum
296
316
13.70
265.59
1.7
1.3
u/ml
7.2
0.6
4.19
24
23
(3037522) Nuclear Ab [Titer] in Serum
500
1060
9.78
259.26
1.9
1.3
titre
1866.9
488.6
32.85
338
228
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
603
1998
7.63
187.68
4.7
2.9
ng/l
676.3
958.5
2.44
563
1672
(3013293) Extractable nuclear Ab [Presence] in Serum
88
13
75.23
162.81
1.7
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
769
3692
10.58
147.29
13.6
5.6
e9/l
0.6
0.6
0.52
746
3170
(3006315) Basophils [#/volume] in Blood
770
3710
10.61
146.64
13.8
5.6
e9/l
0.0
0.0
0.89
747
3187
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
90
25
40.05
146.01
2.5
1.1
ug/l
8.5
9.0
0.24
90
25
(40759836) Histone Ab [Presence] in Serum by Immunoblot
112
64
19.95
140.22
1.4
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
112
64
19.95
140.22
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
112
64
19.95
140.22
1.4
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
774
3835
10.49
140.15
14.3
5.9
e9/l
0.2
0.2
0.28
753
3359
(3019198) Lymphocytes [#/volume] in Blood
768
3790
9.99
139.20
13.8
5.6
e9/l
1.7
1.9
7.57
746
3330
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
112
65
19.64
139.18
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
112
65
19.64
139.18
1.4
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
112
65
19.64
139.18
1.4
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
688
3360
6.07
116.58
14.0
5.8
%
0.8
0.7
4.44
680
3108
(3019069) Monocytes/100 leukocytes in Blood
701
3485
6.28
115.98
14.7
6.0
%
9.0
8.4
7.11
693
3246
(42870588) Differential panel, method unspecified - Blood
579
2479
5.02
115.67
12.9
5.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
698
3468
6.20
115.26
14.1
5.7
%
3.0
2.8
1.90
690
3205
(3018010) Neutrophils/100 leukocytes in Blood
703
3536
6.22
113.68
13.6
5.6
%
58.3
57.0
2.44
693
3289
(3002030) Lymphocytes/100 leukocytes in Blood
705
3567
6.23
112.80
14.2
5.8
%
27.3
28.4
2.43
695
3306
(3013650) Neutrophils [#/volume] in Blood by Automated count
776
4328
8.56
108.91
16.9
8.9
e9/l
3.9
4.0
1.25
752
3787
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
232
529
5.62
100.28
4.4
3.0
ng/l
113.5
163.2
1.68
224
482
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
518
2206
4.35
99.76
3.2
2.1
u/l
105.1
197.3
2.43
503
2069
(3005719) IgG [Mass/volume] in Serum or Plasma
229
548
5.32
93.16
3.4
3.0
g/l
10.3
10.2
0.18
213
500
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
66
33
21.57
87.01
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
97
102
10.58
84.29
1.6
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
79
69
12.50
77.67
1.4
1.1
u/ml
22.7
70.4
—
15
7
(3028026) IgM [Mass/volume] in Serum or Plasma
176
433
4.85
67.86
1.7
1.8
g/l
1.5
1.3
0.63
160
393
(3013707) Erythrocyte sedimentation rate by Westergren method
811
5586
8.00
66.73
11.7
4.2
mm/h
12.6
12.1
0.45
799
5164
(3002179) Metamyelocytes/100 leukocytes in Blood
202
573
4.29
64.70
5.3
3.9
%
0.4
0.6
0.84
40
124
(3025159) Blasts/100 leukocytes in Blood
199
564
4.28
63.75
5.7
4.1
%
0.0
0.8
0.58
42
133
(3035350) Ketones [Presence] in Urine by Test strip
624
3644
3.54
63.13
6.1
3.7
estimate
0.0
0.0
0.00
165
670
(3017181) Myelocytes/100 leukocytes in Blood
211
634
4.08
62.29
5.8
3.9
%
0.7
1.1
0.98
51
180
(40760892) CBC W Ordered Manual Differential panel - Blood
379
1672
3.25
61.51
8.3
4.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
203
600
4.11
61.24
5.8
4.0
%
0.1
0.2
0.65
49
163
(3037467) Urinalysis macro (dipstick) panel - Urine
758
5080
4.91
60.99
9.0
4.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
619
3686
3.37
58.71
7.8
5.1
estimate
0.0
0.0
0.50
170
665
(3009261) Glucose [Presence] in Urine by Test strip
622
3718
3.38
58.54
6.1
3.7
estimate
0.0
0.0
0.80
172
654
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
809
5819
6.83
56.43
14.6
7.1
u/l
76.1
77.6
0.38
802
5466
(3026493) Urate [Moles/volume] in Serum or Plasma
389
1854
2.99
53.48
3.6
2.4
umol/l
660.6
5754.9
5.35
354
1597
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
38
18
22.03
50.85
1.3
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
38
18
22.03
50.85
1.3
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
38
18
22.03
50.85
1.3
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
38
18
22.03
50.85
1.3
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
559
3306
2.94
50.32
3.2
2.3
nmol/l
81.0
78.8
0.98
523
2968
(3006184) Hemoglobin [Mass/volume] in Capillary blood
84
153
5.97
44.89
2.0
2.1
g/l
122.8
129.0
0.78
27
112
(3034770) Mitochondria Ab [Titer] in Serum
94
191
5.40
44.67
1.3
1.2
titre
1019.3
737.0
—
14
10
(3021589) Normoblasts [#/volume] in Blood
544
3300
2.74
44.36
18.1
8.9
e9/l
0.0
0.0
0.16
500
2685
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
578
3659
2.74
42.51
8.3
6.2
mmol/l
1.2
1.2
0.76
489
3078
(3030905) Polymorphonuclear cells [#/volume] in Blood
78
141
5.98
41.96
3.5
3.3
e9/l
3.9
4.4
1.33
78
141
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
310
1454
2.76
41.88
1.4
1.3
iu/ml
40.4
34.1
0.26
132
468
(3018095) Leukocytes [#/volume] in Urine
445
2508
2.59
41.18
5.1
3.5
e6/l
54.5
91.5
0.91
309
1736
(3007566) Smooth muscle Ab [Titer] in Serum
89
185
5.25
41.16
1.2
1.2
titre
82.2
75.0
—
9
16
(3000492) Spirometry study
193
707
3.23
40.72
2.3
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
78
147
5.73
40.15
3.6
3.7
%
57.8
59.2
0.39
78
147
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
532
3315
2.57
39.05
7.6
5.4
mmol/l
1.2
1.2
0.50
493
3003
(3007164) IgA [Mass/volume] in Serum or Plasma
308
1495
2.64
38.27
1.6
1.5
g/l
2.3
2.3
0.08
205
881
(3011397) Hemoglobin [Presence] in Urine by Test strip
334
1717
2.54
36.50
5.7
3.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
247
1103
2.73
35.94
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
84
197
4.61
33.55
2.4
2.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
391
2225
2.38
33.45
4.4
3.6
ph
7.4
7.4
3.10
85
413
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
60
105
6.06
33.27
1.4
1.2
u/ml
5.8
4.7
0.10
24
29
(4268621)
51
76
7.07
33.00
2.2
2.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
185
760
2.82
31.17
2.3
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
347
1932
2.33
30.57
7.3
4.1
estimate
0.0
0.0
0.80
172
660
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
84
219
4.14
29.20
3.1
2.2
ug/l
118.3
238.5
2.33
78
200
(3022948) Iron [Moles/volume] in Serum or Plasma
227
1066
2.53
29.06
3.4
2.3
umol/l
11.4
13.2
2.85
218
984
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
85
233
3.94
27.56
1.8
1.6
iu/ml
0.1
0.1
0.08
14
40
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
42
62
7.07
27.37
2.0
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
199
901
2.57
27.34
3.4
2.3
%
20.3
22.2
1.11
172
771
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
56
112
5.28
26.90
1.4
1.2
u/ml
4.2
6.6
0.39
26
40
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
88
253
3.76
26.65
1.5
1.6
titre
193.3
101.4
—
6
14
(3000850) Epithelial cells [#/volume] in Urine
275
1455
2.30
26.63
3.5
2.4
e6/l
3.8
7.1
4.44
259
1297
(3030467) Casts [#/volume] in Urine by Automated count
333
1925
2.19
25.81
4.1
2.9
e6/l
0.2
0.4
2.07
282
1437
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
313
1771
2.20
25.55
3.6
2.1
mg/l
3.1
3.0
0.11
282
1507
(36304419) Bacteria [Presence] in Urine
327
1891
2.17
25.19
4.1
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
168
728
2.62
25.09
1.4
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
204
976
2.43
24.65
3.4
2.3
g/l
2.3
2.4
0.59
194
902
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
435
2822
2.09
24.59
6.7
3.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
260
1394
2.24
24.00
1.3
1.3
u/ml
14.3
11.1
0.28
106
531
(3011412) CD3 cells [#/volume] in Blood
38
59
6.69
23.62
1.9
2.2
e9/l
1.0
1.1
0.39
25
37
(3020630) Protein [Mass/volume] in Serum or Plasma
141
585
2.68
22.84
1.9
2.7
g/l
65.5
67.2
1.62
130
529
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
57
133
4.52
22.81
1.9
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
465
3148
2.03
22.77
6.2
4.3
g/l
35.4
35.9
1.22
440
2939
(3002582) Erythrocytes [#/volume] in Urine
342
2085
2.06
22.31
4.2
3.0
e6/l
17.6
86.2
1.38
296
1588
(3004588) Protein electrophoresis panel - Serum or Plasma
128
514
2.75
22.07
1.7
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
322
1934
2.06
21.76
11.3
6.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
190
928
2.34
21.64
1.4
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
223
1166
2.23
21.59
3.0
2.5
e6/l
0.6
1.2
4.96
158
647
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
210
1075
2.26
21.39
2.4
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
30
40
7.73
21.33
1.3
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
197
996
2.27
20.59
2.8
1.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
22
21
10.72
20.07
1.1
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
324
2000
1.99
19.90
5.5
3.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
63
176
3.78
19.82
2.0
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
147
665
2.46
19.75
2.7
2.1
g/l
0.2
0.2
2.22
135
630
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
131
4.24
19.70
1.8
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
61
168
3.83
19.58
2.0
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
414
2789
1.93
19.55
9.1
8.0
inr
1.1
1.2
0.40
130
791
(3024980) IgG subclass 4 [Mass/volume] in Serum
49
117
4.38
19.04
1.4
1.8
g/l
0.5
0.9
1.16
39
91
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
102
4.60
18.66
1.9
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
30
47
6.58
18.47
1.9
2.1
%
14.4
12.2
0.21
12
23
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
45
6.63
18.01
1.9
2.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
526
3897
1.89
17.92
7.8
5.8
umol/l
10.1
10.5
0.50
500
3690
(3023368) Bacteria identified in Blood by Culture
289
1766
1.95
17.90
5.0
4.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
832
7400
4.08
17.16
27.8
13.2
mg/l
17.0
21.7
5.17
722
5778
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
282
1736
1.93
16.91
1.3
1.3
u/ml
0.5
1.6
2.63
65
453
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
50
133
3.93
16.85
12.0
5.1
iu/ml
1649.3
159.1
0.79
16
17
(3036481) Cortisol [Moles/volume] in Serum or Plasma
145
697
2.30
16.84
1.6
2.1
nmol/l
351.8
377.9
0.57
133
644
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
46
116
4.13
16.66
1.6
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
20
22
9.28
16.48
1.2
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
151
751
2.22
16.12
2.6
2.6
%
1.9
1.8
0.15
137
675
(40768443) Skin Pathology biopsy report
86
331
2.77
15.95
1.3
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
166
867
2.13
15.64
5.6
4.9
mmol/l
1.0
1.0
0.20
153
796
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
271
2.93
15.62
1.9
2.0
g/l
3.1
3.1
0.10
63
217
(3024139) IgG subclass 3 [Mass/volume] in Serum
35
75
4.82
15.52
1.2
1.3
g/l
0.4
0.4
0.41
26
54
(3028192) IgG subclass 2 [Mass/volume] in Serum
35
75
4.82
15.52
1.2
1.3
g/l
3.0
2.6
0.60
26
54
(3027135) IgG subclass 1 [Mass/volume] in Serum
35
75
4.82
15.52
1.2
1.3
g/l
8.7
7.1
0.49
26
55
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
47
127
3.86
15.50
2.1
1.6
—
—
—
0
0
(4062490)
35
77
4.69
15.05
1.2
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
47
131
3.74
14.83
1.6
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
146
740
2.17
14.80
3.1
4.3
u/l
256.2
254.5
0.03
141
697
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
291
2.81
14.77
1.9
1.9
g/l
3.4
3.8
2.20
61
212
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
292
2.80
14.67
1.9
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
292
2.80
14.67
1.9
1.9
g/l
7.2
7.5
0.87
64
221
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
36
84
4.43
14.41
1.8
1.5
%
54.4
58.6
0.23
21
52
(3021879) Hepatitis B virus core Ab [Presence] in Serum
107
483
2.39
14.26
1.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
165
889
2.06
14.22
2.2
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
112
517
2.34
14.19
2.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
121
584
2.25
13.80
5.9
3.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
39
101
4.00
13.64
1.6
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
116
553
2.27
13.62
2.6
2.7
e9/l
71.6
72.4
0.09
94
427
(3037692) Legionella sp identified in Specimen by Organism specific culture
20
28
7.29
13.59
1.7
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
27
53
5.23
13.23
1.8
1.3
%
40.4
38.3
0.07
12
30
(3001122) Ferritin [Mass/volume] in Serum or Plasma
443
3294
1.71
13.19
3.9
2.7
ug/l
105.7
104.8
0.03
412
3049
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
273
2.74
13.17
2.0
1.9
g/l
10.1
10.2
0.07
64
237
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
145
766
2.07
13.11
2.2
1.7
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
23
39
6.03
13.11
1.4
1.2
ratio
1.1
1.1
—
10
14
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
144
773
2.03
12.43
2.3
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
108
519
2.23
12.41
3.7
2.9
e9/l
4.2
4.0
0.23
76
408
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
19
8.56
12.40
2.4
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
60
219
2.87
12.27
1.5
1.4
ug/g
292.6
304.2
0.16
32
122
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
38
105
3.74
12.16
1.3
1.4
u/ml
125.2
112.6
—
7
20
(46235355) HIV 1 and 2 tests - Meaningful Use set
189
1122
1.88
12.13
1.5
1.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
12
10.98
11.98
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
13
12
10.98
11.98
1.0
1.1
%
100.4
107.2
0.31
13
12
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
374
2707
1.67
11.95
4.7
3.4
ng/l
24.8
44.1
0.77
263
1792
(21494814) CD8 cells/100 lymphocytes in Specimen
17
23
7.52
11.87
2.4
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
53
184
3.00
11.85
1.6
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
92
422
2.32
11.79
4.9
5.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
214
1333
1.80
11.72
4.6
3.8
ng/l
270.7
301.4
0.10
169
993
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
72
297
2.55
11.62
2.0
1.9
g/l
1.5
1.6
0.12
64
260
(3019150) Specific gravity of Urine by Refractometry
244
1584
1.75
11.58
7.3
4.2
kg/l
1.0
1.0
1.08
33
216
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
137
741
2.01
11.54
10.7
7.5
kpa
4.8
5.1
3.37
131
717
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
25
52
4.92
11.48
1.2
1.2
titre
127.1
86.0
—
7
10
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
341
2430
1.66
11.44
5.0
2.9
u/l
31.0
31.6
0.12
328
2309
(3048689) Calprotectin [Mass/mass] in Stool
164
948
1.90
11.36
1.8
2.2
ug/g
189.9
130.5
0.90
135
740
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
28
65
4.42
11.29
1.3
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
28
65
4.42
11.29
1.3
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
28
65
4.42
11.29
1.3
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
85
384
2.35
11.27
2.5
2.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
11
11.05
11.08
4.4
2.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
33
89
3.82
10.94
3.1
2.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
593
4896
1.67
10.79
6.4
4.5
e6/l
163.3
1521.0
—
9
69
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
40
124
3.33
10.79
1.5
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
625
5237
1.69
10.69
5.6
3.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
179
2.90
10.60
1.1
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
115
604
2.04
10.47
3.8
3.5
mmol/l
1.2
1.2
0.76
106
523
(3026782) Osmolality of Urine
212
1357
1.74
10.43
3.9
2.6
mosm/kgh2o
498.1
527.8
1.47
196
1164
(3003396) Base excess in Arterial blood by calculation
134
744
1.95
10.43
10.9
7.5
mmol/l
0.9
1.3
0.63
105
600
(4306422)
34
97
3.61
10.41
1.3
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
21
41
5.22
10.35
1.7
1.4
u/l
10.4
6.1
0.34
14
18
(3045788) Cell count panel - Pleural fluid
22
45
4.99
10.30
1.7
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
27
6.40
10.30
1.1
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
27
6.40
10.30
1.1
1.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
24
53
4.63
10.29
1.7
1.2
e6/l
2691.8
1567.8
0.46
14
36
(3020779) Urea [Moles/volume] in Serum or Plasma
104
530
2.09
10.26
9.5
6.9
mmol/l
9.0
9.0
0.01
97
504
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
38
119
3.29
10.10
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
35
104
3.46
10.09
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
54
4.54
10.06
1.1
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
17
28
6.17
9.95
1.2
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
28
6.17
9.95
1.1
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
12
13
9.35
9.89
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
12
13
9.35
9.89
1.0
1.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
182
1131
1.77
9.88
5.1
3.2
mmol/l
0.8
0.8
0.48
166
1056
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
63
266
2.48
9.70
2.1
1.9
ug/l
1.2
2.1
0.38
55
242
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
85
410
2.19
9.65
5.9
3.3
kpa
5.2
5.1
0.40
80
384
(3029075) Extractable nuclear Ab panel - Serum
17
29
5.96
9.62
1.3
1.0
—
—
—
0
0
(44790049)
29
79
3.76
9.50
2.3
1.5
—
—
—
0
0
(44790048)
29
79
3.76
9.50
2.3
1.5
—
—
—
0
0
(44790047)
29
79
3.76
9.50
2.3
1.5
—
—
—
0
0
(44806118)
29
79
3.76
9.50
2.3
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
350
2608
1.57
9.26
3.1
3.4
mmol/l
2.3
2.4
1.20
306
2292
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
137
796
1.86
9.24
2.6
2.5
umol/l
5.8
6.8
0.38
124
685
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
319
2330
1.58
9.19
3.0
2.3
u/l
59.1
56.4
0.65
290
2136
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
38
5.09
9.12
1.3
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
38
5.09
9.12
1.3
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
38
5.09
9.12
1.3
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
38
5.09
9.12
1.3
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
21
46
4.65
9.10
1.7
1.2
e6/l
5658.5
187795.0
—
10
25
(3021960) Folate [Moles/volume] in Serum or Plasma
248
1711
1.63
9.03
1.7
1.5
nmol/l
22.0
21.9
0.03
215
1450
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
26
68
3.91
9.01
1.8
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
27
73
3.79
8.94
1.3
1.2
u/l
49.2
53.7
0.28
22
51
(3019309) Folate [Moles/volume] in Red Blood Cells
199
1301
1.69
8.92
1.7
1.7
nmol/l
1166.4
1216.9
0.34
157
962
(3008152) Bicarbonate [Moles/volume] in Arterial blood
82
403
2.14
8.88
7.6
8.1
mmol/l
24.2
24.7
0.61
74
385
(3012441) Differential panel - Pleural fluid
21
47
4.55
8.87
1.7
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
388
2990
1.54
8.67
2.1
1.9
pmol/l
95.7
96.8
0.17
194
1457
(3037756) Immunofixation for Serum or Plasma
42
154
2.82
8.56
1.2
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
13
8.56
8.48
3.3
7.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
69
323
2.23
8.43
16.5
10.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
58
255
2.37
8.20
2.4
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
30
93
3.31
8.13
2.2
2.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
213
2.48
8.06
2.3
3.5
mg/l
69.4
76.2
0.07
44
170
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
32
104
3.16
8.05
2.2
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
78
391
2.09
8.03
5.8
3.2
mmol/l
1.8
1.9
0.11
58
300
(3009343) pH of Capillary blood
80
406
2.07
7.97
6.0
3.3
ph
7.4
7.4
0.11
16
56
(3033658) Prothrombin time (PT) actual/Normal
255
1820
1.57
7.89
5.9
3.5
%
91.9
94.3
0.89
244
1766
(40768806) Pleura Pathology biopsy report
21
52
4.11
7.84
1.7
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
21
6.27
7.73
1.2
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
26
76
3.50
7.72
1.8
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
43
169
2.62
7.70
5.2
2.6
mmol/l
24.7
25.1
0.22
37
149
(3026389) Candida sp identified in Specimen by Organism specific culture
31
102
3.11
7.65
1.5
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
109
625
1.85
7.63
6.4
3.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
12
8.42
7.59
2.7
7.8
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
50
213
2.43
7.58
2.3
3.5
mg/l
27.6
39.4
0.38
42
169
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
82
3.37
7.57
2.7
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
15
7.41
7.56
1.2
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
15
7.41
7.56
1.5
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
33
114
2.97
7.50
1.2
1.3
u/ml
332.7
244.8
0.92
20
71
(3045424) Erythrocytes [Presence] in Urine
32
109
3.01
7.45
1.4
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
45
184
2.52
7.45
1.7
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
53
235
2.34
7.37
2.0
1.8
—
—
—
0
0
(3036489) Thrombin time
56
256
2.27
7.26
3.1
1.9
s
22.0
21.1
0.33
47
225
(3034891) Synovial lining cells/100 cells in Synovial fluid
16
34
4.78
7.18
1.6
1.3
%
1.4
5.6
—
5
10
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
106
3.00
7.18
1.0
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
91
503
1.90
7.13
1.4
1.2
u/ml
79.6
221.5
2.07
84
459
(3022145) Colonoscopy Study observation
137
861
1.70
7.00
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
125
2.79
6.93
1.2
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
48
4.02
6.92
2.9
2.9
%
47.2
44.4
—
9
13
(3000475) Leukocytes [#/volume] in Synovial fluid
41
167
2.53
6.85
1.7
1.6
e6/l
4101.4
13041.8
1.47
34
118
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
545
4655
1.46
6.55
3.1
3.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
41
171
2.47
6.53
1.1
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
497
4173
1.45
6.53
7.2
4.3
mmol/l
6.4
6.6
1.05
478
3902
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
37
4.39
6.51
1.1
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
46
203
2.34
6.49
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
160
1075
1.60
6.26
3.6
2.7
e6/l
3.0
3.5
0.21
94
558
(3010144) Erythrocytes [#/volume] in Synovial fluid
21
62
3.45
6.17
1.6
1.4
e6/l
2103.7
126204.5
0.56
15
38
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
26
88
3.01
6.15
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
48
3.81
6.11
2.1
2.0
e6/l
1234.1
679.2
—
9
16
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
65
341
1.98
5.95
15.6
8.4
mmol/l
24.1
24.4
0.41
54
320
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
69
3.25
5.90
1.2
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
307
2394
1.44
5.84
3.6
3.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
18
50
3.66
5.78
2.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
44
201
2.25
5.75
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
91
539
1.77
5.72
14.1
7.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
228
1689
1.47
5.65
2.1
1.7
mg/l
1.5
1.0
0.79
187
1311
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
92
550
1.75
5.61
2.5
2.4
au/ml
45.4
27.9
—
5
24
(36660697) Celiac disease serology panel - Serum
101
623
1.70
5.51
1.2
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
32
130
2.52
5.42
4.1
2.3
%
13.9
16.1
1.66
22
69
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
84
495
1.77
5.38
1.4
1.3
au/ml
49.5
35.8
—
5
26
(3009871) Measles virus Ab [Titer] in Serum
11
22
5.05
5.27
1.5
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
32
132
2.48
5.26
1.7
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
671
6066
1.47
5.25
4.7
4.3
pmol/l
15.2
14.7
5.79
623
5556
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
209
1543
1.47
5.23
1.6
1.7
pmol/l
34682543.8
19388196.9
0.17
173
1274
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
139
2.43
5.20
2.6
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
56
295
1.96
5.09
5.3
3.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
61
331
1.91
5.09
2.0
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
35
155
2.31
4.95
2.0
4.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
94
588
1.67
4.87
3.0
2.5
ml/min/173m2
65.9
66.6
0.06
44
243
(3019225) pH of Specimen
110
724
1.59
4.66
4.7
3.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
32
140
2.33
4.66
1.5
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
186
2.15
4.64
3.3
2.6
u/ml
0.4
0.4
0.04
23
107
(1616796) Gas panel - Central venous blood
30
129
2.37
4.55
4.9
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
95
607
1.63
4.55
4.2
3.2
mmol/l
1.8
2.0
0.18
74
486
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
76
2.81
4.47
3.3
3.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
28
118
2.42
4.44
6.0
2.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
35
3.76
4.38
1.2
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
12
7.57
4.36
1.3
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
17
56
3.08
4.26
1.5
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
108
2.45
4.25
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
570
1.63
4.23
2.5
2.4
ug/l
17.2
6.3
0.57
72
506
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
66
393
1.74
4.12
1.7
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
63
2.90
4.08
2.7
2.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
58
2.97
4.02
1.2
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
750
7041
1.48
3.83
5.8
5.1
mu/l
2.1
2.1
0.02
702
6476
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
33
160
2.10
3.81
1.3
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
43
231
1.91
3.75
3.0
3.0
g/l
0.4
0.2
0.70
19
83
(3017817) Protein [Mass] in Urine collected for unspecified duration
16
55
2.94
3.75
1.8
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
40
210
1.95
3.73
3.0
3.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
53
306
1.78
3.70
5.0
3.0
mmol/l
23.8
24.3
0.46
44
278
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
91
607
1.56
3.66
3.7
3.5
ng/l
79.4
80.0
0.03
75
536
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
16
5.67
3.66
1.9
2.2
—
—
—
0
0
(3013512) EKG study
263
2130
1.34
3.66
5.4
3.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
62
378
1.69
3.58
1.1
1.1
titre
—
78.4
—
0
9
(21494890) Protein electrophoresis panel - 24 hour Urine
18
68
2.68
3.58
1.2
2.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
13
6.20
3.50
1.3
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
63
2.73
3.50
2.1
1.6
—
—
—
0
0
(3010421) pH of Blood
33
166
2.03
3.48
5.4
3.0
ph
7.4
7.4
1.21
27
129
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
47
3.01
3.42
2.3
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
66
415
1.64
3.40
1.6
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
220
2706
0.75
3.36
2.4
2.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
14
5.76
3.34
1.3
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
8
14
5.76
3.34
1.5
1.4
mmol/l
0.8
2.2
—
8
14
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
48
2.95
3.31
2.3
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
97
2.30
3.22
1.1
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
27
130
2.11
3.21
4.3
2.8
umol/l
35.8
33.7
0.14
21
110
(3012501) Base excess in Blood by calculation
27
130
2.11
3.21
6.1
3.2
mmol/l
2.4
2.9
0.42
22
90
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
117
2.17
3.19
1.5
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
19
80
2.41
3.07
3.7
3.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
8
7.54
3.06
1.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
460
0.49
3.04
2.4
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
44
256
1.76
3.03
1.8
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
30
3.36
2.91
1.1
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
30
3.36
2.91
1.1
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
64
2.53
2.88
2.3
2.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
9
6.70
2.87
3.3
1.8
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
9
6.70
2.87
1.3
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
177
1401
1.33
2.81
2.6
2.8
mmol/l
2.5
2.5
0.33
156
1244
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
53
2.67
2.80
2.3
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
23
3.94
2.78
2.3
1.4
—
—
—
0
0
(3020891) Body temperature
45
271
1.70
2.77
5.8
4.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
745
7075
1.38
2.73
22.1
12.2
ml/min/173m2
81.1
81.3
0.10
687
5789
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
655
0.59
2.73
1.5
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
454
0.52
2.70
1.3
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
19
4.24
2.68
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
15
4.70
2.60
3.3
2.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
74
2.32
2.59
1.1
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
100
733
1.41
2.57
4.6
3.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
94
686
1.42
2.48
2.4
2.2
u/l
31.5
37.9
1.12
84
574
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
16
4.40
2.48
1.3
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
54
352
1.57
2.47
3.2
2.6
e6/l
0.1
0.2
0.07
54
341
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
45
2.69
2.46
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
70
2.31
2.42
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
45
694
0.63
2.41
1.3
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
12
5.03
2.40
2.0
7.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
390
3459
1.23
2.39
5.3
3.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
65
445
1.50
2.39
1.5
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
26
139
1.90
2.38
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
26
139
1.90
2.38
1.4
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
78
2.20
2.32
1.1
1.2
—
—
—
0
0
(4010399)
79
567
1.43
2.30
1.7
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
212
1773
1.26
2.19
3.0
2.1
—
—
—
0
0
(3035880) pH of Pleural fluid
9
30
3.02
2.15
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
69
2.19
2.05
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
69
2.19
2.05
2.7
3.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
58
818
0.69
2.04
1.7
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
159
0.37
2.03
1.3
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
76
2.13
2.03
1.3
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
26
3.10
2.01
1.3
1.8
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
10
38
2.65
2.01
1.7
1.3
umol/l
25.6
30.7
—
10
38
(3044941) Cell count panel - Synovial fluid
22
119
1.87
1.98
1.5
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
11
4.56
1.94
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
27
2.98
1.94
3.6
5.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
27
2.98
1.94
1.3
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
16
3.77
1.93
2.7
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
33
2.74
1.93
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
33
2.74
1.93
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
33
2.74
1.93
5.1
2.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
33
2.74
1.93
1.2
2.1
%
102.3
121.2
—
9
33
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
28
166
1.71
1.89
1.2
1.2
e6/l
2.4
16.9
1.35
21
126
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
28
166
1.71
1.89
1.3
1.3
e6/l
473.8
562.5
0.06
22
132
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
34
2.66
1.87
1.1
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
788
7630
1.36
1.86
24.0
14.8
mmol/l
139.3
139.7
3.70
778
7433
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
66
2.14
1.82
1.8
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
12
4.18
1.82
1.0
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
33
210
1.59
1.73
1.3
1.3
miu/ml
213.4
233.4
0.12
15
100
(3006653) Thiamine [Moles/volume] in Blood
8
30
2.68
1.72
1.1
1.2
nmol/l
109.1
152.6
—
8
30
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
96
1.89
1.71
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
96
1.89
1.71
1.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
68
2.08
1.71
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
20
111
1.82
1.70
1.3
1.2
nmol/l
0.8
0.6
1.09
20
106
(3044640) Blood type and Crossmatch panel - Blood
266
2337
1.20
1.68
3.2
2.2
—
—
—
0
0
(4094501)
31
196
1.60
1.67
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
97
1.87
1.67
1.4
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
31
2.59
1.66
2.1
4.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
25
2.81
1.65
2.7
2.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
133
0.37
1.62
1.2
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
98
1.85
1.62
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
98
1.85
1.62
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
33
214
1.56
1.61
2.2
2.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
26
2.71
1.58
3.4
4.0
%
53.6
53.8
—
7
26
(3023103) Potassium [Moles/volume] in Serum or Plasma
787
7648
1.31
1.55
24.2
14.9
mmol/l
3.9
3.9
0.69
776
7438
(1002224) Polysomnography panel
20
332
0.59
1.53
1.1
1.1
—
—
—
0
0
(4015189)
5
15
3.35
1.52
1.4
4.0
—
—
—
0
0
(4035726)
87
684
1.30
1.49
1.6
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
72
1.96
1.49
2.3
2.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
37
2.45
1.48
1.6
3.5
u/ml
1095.3
1269.2
—
9
37
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
39
270
1.47
1.44
2.1
2.8
u/ml
24.2
699.7
0.75
31
235
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
95
1.81
1.44
1.4
1.2
nmol/l
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
276
0.57
1.42
1.6
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
46
2.19
1.40
1.7
2.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
96
1.79
1.39
1.4
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
111
909
1.25
1.39
9.0
6.8
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
23
2.62
1.37
1.3
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
15
82
1.84
1.36
3.1
2.1
pg
32.9
32.1
0.24
15
82
(3033799) Differential panel - Peritoneal fluid
5
17
2.95
1.36
2.4
2.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
102
837
1.25
1.27
27.1
22.1
inr
1.0
1.2
3.12
16
108
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
44
2.06
1.27
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
107
1.70
1.26
1.1
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
36
2.23
1.24
1.4
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
31
213
1.47
1.22
5.9
3.7
mmol/l
3.9
3.8
0.51
31
197
(3044007) Cell count panel - Peritoneal fluid
5
20
2.51
1.15
2.8
2.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
791
7733
1.26
1.15
22.9
12.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
58
1.91
1.12
1.4
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
40
2.01
1.12
2.1
3.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
345
3181
1.14
1.11
2.3
2.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
104
1.65
1.10
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
152
1.53
1.10
1.3
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
21
2.39
1.09
1.2
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
834
8218
1.39
1.07
41.1
19.7
e9/l
261.5
258.6
0.63
829
8011
(4034850)
33
237
1.41
1.06
8.8
9.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
147
0.54
1.04
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
147
0.54
1.04
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
147
0.54
1.04
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
147
0.54
1.04
1.1
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
834
8221
1.38
1.03
41.1
19.7
e12/l
4.4
4.4
6.69
828
7996
(3010813) Leukocytes [#/volume] in Blood
834
8222
1.38
1.02
41.1
19.7
e9/l
6.6
6.6
0.15
828
7995
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
13
77
1.70
0.95
15.7
6.7
mg/l
12.8
12.3
0.13
13
71
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
51
1.77
0.94
1.0
1.3
mmol/l
2.5
2.0
—
9
51
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
37
1.90
0.94
2.1
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
172
0.58
0.94
1.5
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
193
1.41
0.91
1.6
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
102
0.49
0.90
1.0
1.5
—
—
—
0
0
(4027681)
8
43
1.87
0.87
1.4
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
44
1.83
0.86
3.6
3.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
251
0.67
0.86
1.2
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
17
112
1.53
0.85
2.3
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
177
1589
1.14
0.84
1.4
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
112
0.53
0.83
2.0
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
32
1.88
0.82
1.0
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
189
1.39
0.82
1.1
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
207
1.36
0.80
1.5
2.0
u/l
2214.2
2984.0
—
9
85
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
10
58
1.73
0.80
1.2
1.1
—
1.0
—
0
8
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
190
1.38
0.79
1.2
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
42
331
1.28
0.79
1.6
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
60
494
1.23
0.78
3.7
2.9
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.1
—
26.9
—
0
19
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
99
0.50
0.78
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
39
306
1.29
0.76
1.4
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
54
1.67
0.74
1.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
38
1.85
0.73
2.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
31
239
1.31
0.70
1.3
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
675
6914
0.89
0.69
5.1
5.5
mmol/mol
38.5
39.3
0.85
630
6425
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
85
1.54
0.69
1.1
1.0
u/ml
0.3
3.3
—
6
29
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
61
1.65
0.68
1.4
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
57
678
0.83
0.67
1.8
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
154
1.37
0.65
3.9
2.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
296
1.26
0.64
1.5
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
291
0.75
0.63
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
206
1903
1.11
0.62
1.4
1.4
—
—
—
0
0
(4146454)
11
71
1.56
0.62
3.6
2.7
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
49
1.64
0.62
1.0
1.5
ug/l
6.6
6.1
—
8
39
(3017446) Testosterone [Moles/volume] in Serum or Plasma
31
244
1.28
0.62
2.1
2.2
nmol/l
12.9
12.6
0.04
25
216
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
511
4927
1.09
0.61
4.2
3.0
u/l
56.6
46.2
1.94
480
4606
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.2
—
2.5
—
0
9
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
67.0
—
0
6
(3035933) Granulocytes/100 leukocytes in Blood
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
81
1.49
0.57
1.1
1.0
u/ml
1.1
6.3
—
6
25
(3004451) EKG impression Narrative
6
36
1.67
0.56
1.7
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
60
516
1.17
0.54
1.8
3.1
pmol/l
4.2
4.5
2.33
49
453
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
61
1.48
0.54
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
61
1.48
0.54
1.1
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
74
1.49
0.53
1.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
98
0.61
0.52
1.3
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
149
1369
1.11
0.51
1.7
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
64
557
1.16
0.51
1.3
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
47
399
1.19
0.50
1.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
216
1.26
0.50
1.4
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
46
1.53
0.48
1.6
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
46
1.53
0.48
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
30
245
1.23
0.47
1.4
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
120
1.34
0.46
1.2
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
120
1.34
0.46
1.1
1.1
u/ml
0.5
2.0
—
9
48
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
49
1.43
0.46
2.0
6.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
69
1.45
0.44
1.4
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
30
248
1.22
0.43
1.4
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
85
766
1.12
0.43
2.4
3.9
ug/l
4.4
25.7
1.28
66
611
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(4024509)
8
61
1.31
0.39
2.1
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
193
0.77
0.39
1.1
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
80
1.38
0.38
1.2
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
116
1.30
0.37
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
244
1.20
0.36
1.3
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
54
604
0.89
0.34
1.7
1.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
12
91
1.32
0.34
1.3
1.4
pmol/l
239.3
312.7
—
7
70
(3023323) Follitropin [Units/volume] in Serum or Plasma
35
403
0.86
0.33
1.5
1.3
iu/l
33.4
30.9
0.15
28
339
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
87
0.69
0.33
2.0
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
684
6743
1.07
0.32
29.1
14.5
%
39.1
39.4
0.52
448
4885
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
47
1.28
0.32
2.0
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
101
938
1.09
0.31
1.2
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
22
184
1.20
0.30
2.9
2.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
101
941
1.08
0.29
4.0
4.4
%
34.6
32.9
0.81
73
617
(3023410) Appearance of Cerebral spinal fluid
10
76
1.32
0.28
1.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
194
0.82
0.28
1.1
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
194
0.82
0.28
1.1
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
193
0.83
0.27
1.1
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
67
1.20
0.26
1.1
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
67
1.20
0.26
1.3
1.7
ug/l
12.1
19.9
—
8
67
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
32
282
1.14
0.26
1.7
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
40
359
1.12
0.25
1.9
1.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
27
236
1.15
0.24
1.7
1.6
mu/l
370.5
289.6
0.73
22
211
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
115
1.22
0.23
1.4
1.1
—
13.6
—
0
9
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
179
0.84
0.23
1.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
42
381
1.11
0.22
4.1
3.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
212
2046
1.05
0.22
1.5
1.6
mmol/l
1.3
1.4
1.35
172
1726
(3003740) Influenza virus B Ag [Presence] in Specimen
14
116
1.21
0.22
1.1
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
5
42
1.19
0.21
1.0
1.0
ng/l
422.2
352.7
—
5
26
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
5
42
1.19
0.21
1.0
1.0
ng/l
57.4
52.3
—
5
26
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
5
42
1.19
0.21
1.0
1.0
ng/l
1115.0
660.9
—
5
24
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
10
0.00
0.21
0.0
1.9
—
120.7
—
0
10
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
53.6
—
0
10
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.7
—
20.3
—
0
12
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
12
0.00
0.21
0.0
3.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
80
1.25
0.20
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
49
1.23
0.20
1.5
1.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
114
0.79
0.20
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
212
2188
0.96
0.19
4.1
3.8
mg/mmol
20.7
7.3
1.16
134
1286
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
51
1.18
0.19
1.3
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
76
716
1.07
0.19
3.8
4.0
%
21.1
21.8
0.17
33
325
(3004716) Salmonella sp identified in Stool by Organism specific culture
44
406
1.09
0.18
1.6
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
153
0.85
0.18
3.8
3.8
mg/l
28.7
22.4
—
7
94
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
73
1.10
0.15
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
84
1.19
0.14
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
122
1.15
0.14
1.2
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
159
0.88
0.13
2.2
2.3
ug/min
31.0
88.7
—
6
95
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
106
0.85
0.13
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
104
1.16
0.12
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
133
1.13
0.12
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
64
670
0.95
0.12
1.7
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
105
1.14
0.11
1.0
1.0
u/ml
1.4
0.8
—
6
43
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
125
0.88
0.10
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
185
0.92
0.08
4.6
4.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
70
0.86
0.07
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
94
916
1.03
0.07
4.6
4.3
ug/l
2.4
2.3
0.08
83
812
(3032773) Endomysium IgG Ab [Titer] in Serum
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
755
7575
0.97
0.07
4.6
4.9
mmol/l
2.6
2.8
7.74
707
6987
(40768795) Lymph node Pathology biopsy report
8
78
1.03
0.07
1.4
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
118
1.10
0.07
1.2
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
110
1.09
0.05
1.0
1.0
u/ml
0.9
3.0
—
7
54
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
745
7431
1.02
0.05
4.3
4.4
mmol/l
4.6
4.8
5.83
698
6876
(3009508) Creatinine [Moles/volume] in Urine
217
2192
0.99
0.04
3.4
3.0
mmol/l
6.4
6.9
1.06
184
1848
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
54
526
1.03
0.04
2.8
2.7
ug/l
0.6
0.7
0.47
30
319
(3012516) Albumin [Mass/volume] in Urine
206
2079
0.99
0.04
3.4
3.1
mg/l
1360.8
312.2
0.97
130
1220
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
149
0.94
0.03
1.1
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
729
7280
1.01
0.01
4.3
4.5
mmol/l
5.6
5.9
9.31
676
6648
(3013139) Helicobacter pylori Ag [Presence] in Stool
54
532
1.02
0.01
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
58
586
0.99
0.00
1.1
1.2
iu/ml
80.6
152.1
1.46
15
245
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
714
7146
1.00
0.00
3.8
3.9
mmol/l
1.2
1.3
5.81
668
6533
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
15
146
1.03
0.00
5.5
1.6
nmol/l
0.8
0.9
0.37
15
119
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
740
7397
1.00
0.00
4.2
4.4
mmol/l
1.6
1.5
2.52
691
6807
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
79
789
1.00
0.00
1.3
1.7
%
1.6
1.4
0.84
62
698
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
165
0.97
0.00
1.7
1.6
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
5
52
0.96
0.00
1.4
1.6
—
9.8
—
0
5
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
50
1.00
0.00
1.0
1.1
—
7.2
—
0
12
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
78
0.90
0.00
1.1
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
88
0.91
0.00
1.0
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(4281824)
9
99
0.91
0.00
1.1
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
5
59
0.85
0.00
1.4
1.2
nmol/l
365.0
386.7
—
5
52
(44813793)
5
58
0.86
0.00
1.2
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
5.4
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: SYSTSCLE_ICD10 – Systemic sclerosis, icd10

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).